About NetScientific

NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society.

NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand.

NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.

 

An entrepreneur-led senior management team with extensive biomedical, healthcare and commercial experience.


  • Sir Richard Sykes FRS

  • François Martelet MD

  • Michael Boyce-Jacino PhD

  • David Gough MBA

  • Peter Thoms FCA

Our Portfolio

Digital Health

wanda-logo.png

WANDA Health

Healthcare Analytics Platform technology focused on delivering clinical grade actionable data in remote settings

Triventis_Logo.png

Triventis Health

Digital Health sales and marketing company formed in partnership with iMPak Health, a wholly owned subsidiary of US hospital group, Meridian Health, NJ

glucosense-logo.png

Glucosense

Non-invasive glucose monitoring wearable device for the medical and consumer wellness market

g-tech-medical-logo.png

G-Tech Medical

‘EKG for the gut’ - Wearable patch technology for diagnosis and monitoring of functional gastric disorders

neumita-logo.png

Neumitra

Wearable devices and smart software applications for the real-time management of stress

Diagnostics

vortex-logo.png

Vortex Biosciences

Circulating Tumor Cell identification, selection and analysis for disease monitoring and personalised therapeutic prescribing

glycotest-logo.png

Glycotest

Unique, non-invasive blood tests for liver cancers and fibrosis-cirrhosis

ProAxsis-logo.png

ProAxsis

Respiratory disease diagnosis and treatment monitoring – Cystic Fibrosis and COPD

Therapeutics

PDS-logo.png

PDS Biotechnology

Novel cancer / infectious disease immunotherapeutic drug development company

EPIbone-logo.png

EpiBone

Regenerative medicine company growing bones from stems cells

longevity-logo.png

Longevity Biotech

Developing new class of therapeutic compounds based on Hybridtides in Metabolic, Neurology, Infectious disease and oncology applications

Unique Partnership Model



The partnership with Breakout Labs provides NetScientific and its investors with access to some of the most revolutionary new technologies coming out of Silicon Valley and beyond.

Breakout-Labs.png